{'52WeekChange': 'Infinity',
 'SandP52WeekChange': None,
 'address1': '4200 Marathon Boulevard',
 'address2': 'Suite 200',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 17,
 'askSize': 900,
 'averageDailyVolume10Day': 18387,
 'averageVolume': 31398,
 'averageVolume10days': 18387,
 'beta': None,
 'beta3Year': None,
 'bid': 15.05,
 'bidSize': 1000,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'Austin',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 15.51,
 'dayLow': 15.11,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -4.511,
 'enterpriseToRevenue': None,
 'enterpriseValue': 41239676,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 15.629714,
 'fiftyTwoWeekHigh': 17.5,
 'fiftyTwoWeekLow': 1.13,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': None,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 27,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.13003,
 'heldPercentInstitutions': 0.39993,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1546214400,
 'lastMarket': None,
 'lastSplitDate': 1584576000,
 'lastSplitFactor': '1:9',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/lumos-pharma.com',
 'longBusinessSummary': 'Lumos Pharma, Inc., a clinical stage '
                        'biopharmaceutical company, focuses on the development '
                        'and commercialization of therapeutics for severe, '
                        'rare, and genetic diseases. Its lead therapeutic '
                        'candidate LUM-201 is an oral growth hormone '
                        'stimulating small molecule, which is in Phase 2 '
                        'clinical trial for the treatment of pediatric growth '
                        'hormone deficiency. The company has a licensing '
                        'agreement with Ellipses Pharma Limited for the '
                        'development of and rights to commercialize '
                        'nanoparticle formulations of two therapeutics for '
                        'oncology indications. Lumos Pharma, Inc. was founded '
                        'in 2011 and is headquartered in Austin, Texas.',
 'longName': 'Lumos Pharma, Inc.',
 'market': 'us_market',
 'marketCap': 126465200,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_256380672',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -9051000,
 'nextFiscalYearEnd': 1609372800,
 'open': 15.3,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.37,
 'phone': '512 215 2630',
 'previousClose': 15.39,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 15.51,
 'regularMarketDayLow': 15.11,
 'regularMarketOpen': 15.3,
 'regularMarketPreviousClose': 15.39,
 'regularMarketPrice': 15.3,
 'regularMarketVolume': 10459,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 8292800,
 'sharesPercentSharesOut': 0.0271,
 'sharesShort': 224845,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 191799,
 'shortName': 'Lumos Pharma, Inc.',
 'shortPercentOfFloat': 0.0421,
 'shortRatio': 6.64,
 'startDate': None,
 'state': 'TX',
 'strikePrice': None,
 'symbol': 'LUMO',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 10.891845,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'bcffe56f-50ef-3693-86d2-3838602f9308',
 'volume': 10459,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.lumos-pharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '78756'}